QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 endra-life-sciences-granted-extension-to-regain-compliance-with-nasdaq-continued-listing-requirements

ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that on Augu...

 endra-life-sciences-q2-2024-gaap-eps-008-misses-004-estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of...

 endra-life-sciences-announces-alexander-tokman-appointed-as-acting-ceo-to-replace-francois-michelon-who-stepped-down-from-his-role-as-ceo-and-as-a-member-of-the-board-of-directors-to-pursue-other-endeavors-appoints-richard-jacroux-as-cfo

Board Member Alexander Tokman appointed as acting CEO bringing 24+ years of global commercial leadership experienceTwo addition...

 why-endra-life-sciences-stock-is-trading-higher-monday

ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.

 endra-life-sciences-13g-filing-shows-shn-financial-investments-ltd-reported-a-999-stake-in-the-co-as-of-june-4-2024

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION